MPEP, an mGlu5 receptor antagonist, reduces the development of l-DOPA-induced motor complications in de novo parkinsonian monkeys: Biochemical correlates
暂无分享,去创建一个
L. Grégoire | F. Gasparini | B. Gomez-Mancilla | S. Desrayaud | M. Morissette | T. Paolo | N. Morin